Posters (Abstracts 264-2239)

Citation data:

Hepatology, ISSN: 0270-9139, Vol: 66, Issue: S1, Page: 149-1185

Publication Year:
2017
Usage 35
Abstract Views 35
Captures 19
Readers 19
Mentions 1
News Mentions 1
Social Media 3
Tweets 3
Citations 1
Citation Indexes 1
Repository URL:
https://engagedscholarship.csuohio.edu/scichem_facpub/472; https://engagedscholarship.csuohio.edu/scichem_facpub/471
DOI:
10.1002/hep.29501
Author(s):
Allawy, Allawy; Singh, Dharmvir; Tsien, Cynthia; Shah, Rohan R.; Alchirazi, Khaled Alsabbagh; O'Shea, Robert; McCullough, Arthur J.; Dasarathy, Jaividhya; Davuluri, Gangarao; Sandlers, Yana; Dasarathy, Srinivasan Show More Hide
Publisher(s):
Wiley
Tags:
Biochemistry; Digestive System Diseases
Most Recent Tweet View All Tweets
Most Recent News Mention
article description
Background. Skeletal muscle hyperammonemia occurs in cirrhosis and contributes to sarcopenia or loss of skeletal muscle mass. Skeletal muscle ammonia disposal occurs in the mitochondria by cataplerosis (loss of tricarboxylic acid- TCA- cycle intermediates) of a-ketoglutarate to generate glutamate and glutamine. Skeletal muscle hyperammonemia also results a unique cellular stress response with partitioning of L-leucine into the mitochondria to assist ammonia disposal, potentially promoting anaple- rosis (entry of TCA cycle intermediates) either directly or indirectly. We have previously reported that skeletal muscle hyperammonemia decreases cellular oxygen consumption, lowers tricarboxylic acid cycle intermediates and increases mitochondrial reactive oxygen species in the muscle. We therefore hypothesized that ammonia induced skeletal muscle mitochondrial dysfunction will be reversed by L-leucine supplementation that is sufficient to satisfy the metabolic demand in the mitochondria. Methods. Differentiated C2C12 murine myotubes were treated with 10mM ammonium acetate or vehicle alone and the response to L leucine 5mM was quantified. Cellular oxygen consumption in the basal state and the response to substrates for components of the electron transport chain (pyruvate and malate for complex I; succinate for complex II) were measured using high sensitivity respirometry in intact and permeabilized myotubes. Concentration of TCA cycle intermediates in cell lysates were quantified using isotope ratio mass spectrometry respectively. Mitochondrial reactive oxygen species were measured by flow cytometry using the fluoroprobe, MitoSox®. ATP content was measured by a fluorometric assay. Complementary studies were performed in myotubes grown in leucine deficient medium that were treated with L-leu- cine. All experiments were done in at least 4 biological replicates. Results. Hyperammonemia decreased intact cell and substrate dependent oxygen consumption in myotubes that were reversed by 5mM L-leucine. Increased reactive oxygen species during hyperammonemia was also decreased by L-Leucine Hyperammonemia resulted in a reduction in TCA cycle intermediates and the intermediate ratios at 6 and 24 h that was reversed by L-leucine. Low cellular ATP content and ATP synthesis were also reversed by L-leucine supplementation. L-leucine deficient medium resulted in a depletion of TCA cycle intermediates that was aggravated by hyperammonemia and reversed by L leucine. Conclusions. We demonstrate for the first time that ammonia induced skeletal muscle mitochondrial dysfunction is reversed by L leucine supplementation and restores the anaplerosis/cataplerosis balance.